Immune checkpoint inhibitor responses in humanized mouse melanoma models using patient-derived xenografts.

被引:0
|
作者
Somasundaram, Rajasekharan [1 ]
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA USA
关键词
D O I
10.1200/JCO.2017.35.7_suppl.99
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
99
引用
收藏
页数:1
相关论文
共 50 条
  • [31] EXPLORATION OF RESISTANCE OF PARP INHIBITOR THERAPY IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENT-DERIVED XENOGRAFTS.
    Ye, L.
    Topp, M.
    Boehm, E.
    Hadley, A.
    Cook, M.
    Heong, V.
    Pyman, J.
    McNally, O.
    Ananda, S.
    Harrell, M.
    Alsop, K.
    Bowtell, D. D.
    Johnson, N.
    Kaufmann, S. H.
    Swisher, E. M.
    Wakefield, M.
    Scott, C. L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 407 - 408
  • [32] Strategies for the Construction of Mouse Models With Humanized Immune System and Evaluation of Tumor Immune Checkpoint Inhibitor Therapy
    Guo, Wenwen
    Zhang, Caiqin
    Qiao, Tianyun
    Zhao, Jumei
    Shi, Changhong
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Humanized Rag2 mice as patient-derived orthotopic mouse models for immune checkpoint blockade and conventional chemotherapeutic drug treatment for human solid tumors
    Li, Li
    Zhang, Xin
    Maresh, Grace
    Mathew, Neeha
    Bhattarai, Amita
    Hellmers, Linh
    Yip, Henry
    Moret, Ravan
    Baste, Lara McKean
    Green, Heather
    Latsis, Maria
    Bardot, Stephen
    Margolin, David
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [34] Engraftment of patient derived xenografts on mice with a humanized immune system
    Wulf-Goldenberg, Annika
    Stecklum, Maria
    Eckert, Klaus
    Behrens, Diana
    Fichtner, Iduna
    Hoffmann, Jens
    [J]. CANCER RESEARCH, 2015, 75
  • [35] MEASURING IMMUNE CHECKPOINT INHIBITOR EFFICACY USING PRIMARY PATIENT-DERIVED 3D SPHEROIDS
    Appleton, Kathryn
    Lassahn, Katy
    Elrod, Ashley
    DesRochers, Tessa
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A305 - A305
  • [36] Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma
    Yan, Chi
    Nebhan, Caroline A.
    Saleh, Nabil
    Shattuck-Brandt, Rebecca
    Chen, Sheau-Chiann
    Ayers, Gregory D.
    Weiss, Vivian
    Richmond, Ann
    Vilgelm, Anna E.
    [J]. CANCERS, 2023, 15 (14)
  • [37] Preclinical models for translational immuno-oncology research: patient-derived xenografts on humanized mice.
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Klinghammer, Konrad
    Joehrens, Korinna
    Walther, Wolfgang
    Hoffmann, Jens
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [38] Immune Checkpoint Inhibitor for a Pediatric Melanoma Patient
    Itakura, Yosuke
    Uchimura, Shinsuke
    Kawakami, Ryota
    Shimizu, Daisuke
    Kageyama, Reiko
    Senoo, Ayumu
    Matsushita, Yuki
    Sakaguchi, Kimiyoshi
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S119 - S119
  • [39] Preclinical models for translational immuno-oncology research: Rare patient-derived xenografts on humanized mice
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Walther, Wolfgang
    Hoffmann, Jens
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [40] Patient-derived xenografts as compatible models for precision oncology
    Sung-Yup Cho
    [J]. Laboratory Animal Research, 36